Jonathan Barron is a corporate and securities lawyer in the New York office of K&L Gates. His practice focuses on various corporate and securities law matters, including mergers and acquisitions, financing transactions, commercial contracts, and advising public companies on securities law compliance, securities offerings, and corporate governance. Jonathan’s practice also includes advising private equity firms, investment fund managers, service providers and portfolio companies on a wide variety of transactions, including seeding arrangements, investment manager M&A transactions, and other corporate and finance-related matters.
Jonathan has worked extensively with many clients in the generic pharmaceutical industry on U.S. and cross-border development, supply and other commercial contracts. On the M&A side, he represented an NYSE-listed pharmaceutical manufacturer in the acquisition of abbreviated new drug applications (ANDAs) and related assets, and an international pharmaceutical company which purchased ANDAs and related assets as part of an FTC ordered divestiture.
Jonathan has represented a major financial institution in the negotiation of an exclusive co-branded credit card agreement. He has also advised borrowers and lenders on secured credit facilities, including one secured by IP held in a special purpose vehicle and others secured by solar renewable energy credits. He has represented established and start-up private companies in preferred stock offerings and also public companies in various PIPE offerings.
Jonathan has experience negotiating various agreements in the merchant cash advance (MCA) industry. He has also advised clients on services, supply, and consulting agreements across various industries, including programmatic advertising, software development, and the Internet of Things (IoT).
